Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biovail Corporation
Biovail Comments on Filing of Lawsuit
October 25th, 2008
Biovail Corporation (NYSE, TSX: BVF) announced that it has been notified that a proposed securities class action lawsuit has been filed in the U.S. District Court Southern District of New York against the Company, its Chairman and two former officers. The complaint has been filed on behalf of all persons and entities that purchased Biovail securities from December 14, 2006 through July 19, 2007. The complaint relates to statements alleged to have been made by the Company and by certain officers in respect of Aplenzin(TM) (bupropion hydrobromide tablets) during the product's U.S. regulatory approval process. Biovail believes the claim is completely...
Source: Law & Health Weekly (2008-10-25)
|
